Back to discover
Drug

Epoetin alfa

Established medicine
ResearchOngoing research
Also known as E.P.O., EPOETIN, ERYTHROPOIETIN, Epogen+10 more

E.P.O., EPOETIN, ERYTHROPOIETIN, Epogen, Erythropoetin, Procrit, Retacrit, epo, rhEPO, Epoetina alfa, EPOETIN ALFA,RECOMBINANT, Epoetin alfa rDNA, Epoetin alfa, recombinant, RECOMBINANT HUMAN ERYTHROPOIETIN ALFA.

RxNorm105694UNII64FS3BFH5W
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Epoetin alfa
Aliases & brands
E.P.O.EPOETINERYTHROPOIETINEpogenErythropoetinProcritRetacriteporhEPOEpoetina alfaEPOETIN ALFA,RECOMBINANTEpoetin alfa rDNAEpoetin alfa, recombinantRECOMBINANT HUMAN ERYTHROPOIETIN ALFA
RxNorm CUI
105694
UNII
64FS3BFH5W

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • American journal of nephrology1
Leading researchers
  • Kalantar-Zadeh K1
Leading institutions
free-text, unnormalised
  • Harold Simmons Center for Kidney Disease Research and Epidemiology1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature